GeneDx Holdings (WGS)
NASDAQ:WGS
US Market
Holding WGS?
Track your performance easily

GeneDx Holdings (WGS) Financial Statements

394 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently ―. The company's EPS TTM is $-5.246; its P/E ratio is -6.25; GeneDx Holdings is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 62.42M$ 53.30M$ 48.71M$ 43.14M-
Gross Profit$ 37.41M$ 25.26M$ 17.70M$ 13.49M-
EBIT$ -19.72M$ -43.51M$ -46.29M$ -57.65M-
EBITDA$ -19.72M-$ -46.16M$ -57.52M-
Net Income Common Stockholders$ -20.24M$ -42.29M$ -46.72M$ -60.99M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 112.91M$ 114.30M$ 156.66M$ 214.04M$ 137.37M
Total Assets$ 394.53M$ 417.29M$ 476.39M$ 545.30M$ 490.91M
Total Debt$ 52.29M$ 6.05M$ 6.25M$ 6.25M$ 6.25M
Net Debt$ -60.62M$ -108.25M$ -150.41M$ -207.79M$ -131.12M
Total Liabilities$ 187.31M$ 163.03M$ 180.28M$ 216.83M$ 237.24M
Stockholders Equity$ 207.22M$ 254.26M$ 296.11M$ 328.47M$ 253.71M
Cash Flow-
Free Cash Flow$ -16.86M-$ -52.65M$ -55.56M-
Operating Cash Flow$ -16.41M$ -41.23M$ -53.52M$ -55.56M-
Investing Cash Flow$ 843.00K$ -27.13M$ -11.27M$ -462.00K-
Financing Cash Flow$ -438.00K$ -911.00K$ 7.39M$ 132.66M-
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis